This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Phathom Pharmaceuticals attends...
Business investor conference

Phathom Pharmaceuticals attends investor conferences

Analysis based on 6 articles · First reported May 22, 2026 · Last updated May 22, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The participation of Phathom Pharmaceuticals in these investor conferences provides an opportunity for the company to engage with investors and potentially attract new investments. This increased visibility could lead to a positive impact on the stock price of Phathom Pharmaceuticals.

Pharmaceuticals Biotechnology
Event Summary

Phathom Pharmaceuticals, a biopharmaceutical company specializing in gastrointestinal diseases, announced its participation in several upcoming investor conferences in May and June 2026. Management will attend the Craig-Hallum Capital Group 23rd Annual Institutional Investor Conference, the Jefferies Global Healthcare Conference, and the Goldman Sachs 47th Annual Global Healthcare Conference. These events will include one-on-one meetings and fireside chats, providing Phathom Pharmaceuticals an opportunity to present its business, including its key product vonoprazan (Vonoprazan), to a broad investor audience. Webcasts and archived recordings of the events will be available on the company's investor relations website.

Entities Involved
stock
Phathom Pharmaceuticals
Phathom Pharmaceuticals is participating in several investor conferences to present its business and engage with investors, which could positively impact its stock price and visibility.
Importance 100.0 Sentiment 10.0
oth
Vonoprazan
Vonoprazan is a registered trademark of Phathom Pharmaceuticals, representing its key product.
Importance 10.0 Sentiment 0.0
per
Nick Benedetto
Nick Benedetto is the media contact for Phathom Pharmaceuticals.
Importance 5.0 Sentiment 0.0
per
Eric Sciorilli
Eric Sciorilli is the investor contact for Phathom Pharmaceuticals.
Importance 5.0 Sentiment 0.0
priv
Jefferies
Importance 0.0 Sentiment 0.0
stock
Goldman Sachs
Importance 0.0 Sentiment 0.0
priv
Craig-Hallum Capital Group
Importance 0 Sentiment 0
Relationships
Jefferies related ↔ Goldman Sachs
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.